ADVERTISEMENT

Motilal Oswal: Piramal Enterprises’ Lending Business Stable In Q2, Pharma Showing Healthy Traction

With Gross NPAs at 2.5%, Piramal Enterprises’ asset quality was stable in Q2 even as its pharma business grew 10% year-on-year.

Billionaire Ajay Piramal, chairman of Piramal Group during an interview in Mumbai, India. Photographer: Dhiraj Singh/Bloomberg 
Billionaire Ajay Piramal, chairman of Piramal Group during an interview in Mumbai, India. Photographer: Dhiraj Singh/Bloomberg 
BQ Blue’s special research section collates quality and in-depth equity and economy research reports from across India’s top brokerages, asset managers and research agencies. These reports offer BloombergQuint’s subscribers an opportunity to expand their understanding of companies, sectors and the economy.
To continue reading this story
Subscribe to unlock & enjoy all Members-only benefits

Choose a plan

Renews automatically. Cancel anytime.
Still Not convinced ? Know More